{
"id":"mk19_b_gm_t34",
"number":34,
"bookId":"gm2",
"title":{
"__html":"Medications for Weight Loss"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"24aadf",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 34. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_gm_t34"
}
]
},
"Medications for Weight Loss"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"353bd6",
"class":"col hd l",
"children":[
"Medication"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6cdc4b",
"class":"col hd l",
"children":[
"Mechanism of Action"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f42437",
"class":"col hd l",
"children":[
"Weight Loss Versus Placebo at 52 Weeks in Meta-analysis of Randomized Controlled Trials"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b8d7fa",
"class":"col hd l",
"children":[
"Common Side Effects (Odds Ratio for Discontinuation Versus Placebo)"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cb0781",
"class":"cell txt l",
"children":[
"Liraglutide (injectable)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8982cd",
"class":"cell txt l",
"children":[
"GLP-1 receptor agonist; delays gastric emptying"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d704a7",
"class":"cell txt l",
"children":[
"5.2 kg (11.6 lb)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"df3125",
"class":"cell txt l",
"children":[
"Gastrointestinal upset, headache, nasopharyngitis (2.82)"
]
},
" ",
{
"type":"p",
"hlId":"c816d0",
"class":"cell txt l",
"children":[
"Contraindications: MTC, MEN2, pregnancy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d462d9",
"class":"cell txt l",
"children":[
"Naltrexone-bupropion"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e5b1ae",
"class":"cell txt l",
"children":[
"Opioid antagonist plus norepinephrine/dopamine uptake inhibitor; suppresses appetite"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ba60f4",
"class":"cell txt l",
"children":[
"5 kg (10.9 lb)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c897bb",
"class":"cell txt l",
"children":[
"Gastrointestinal upset, headache, dizziness, insomnia, dry mouth, tachycardia, hypertension, anxiety, tremor (2.60)"
]
},
" ",
{
"type":"p",
"hlId":"159bb3",
"class":"cell txt l",
"children":[
"Contraindications: opioid use or withdrawal, uncontrolled hypertension, history of seizures, eating disorder"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ddc016",
"class":"cell txt l",
"children":[
"Orlistat"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8c6d60",
"class":"cell txt l",
"children":[
"Lipase inhibitor; decreases triglyceride absorption"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"29a08a",
"class":"cell txt l",
"children":[
"2.6 kg (5.8 lb)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"14d1c4",
"class":"cell txt l",
"children":[
"Oily stools, increased defecation, fecal urgency/incontinence (1.84)"
]
},
" ",
{
"type":"p",
"hlId":"a76bb4",
"class":"cell txt l",
"children":[
"Contraindications: pregnancy, malabsorption syndrome, cholestasis"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"23ffe3",
"class":"cell txt l",
"children":[
"Phentermine-topiramate"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"64ed21",
"class":"cell txt l",
"children":[
"Noradrenergic/GABA receptor activator and AMPA glutamate receptor inhibitor; suppresses appetite"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a11b98",
"class":"cell txt l",
"children":[
"8.8 kg (19.4 lb)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5974ce",
"class":"cell txt l",
"children":[
"Paresthesias, dizziness, taste alterations, insomnia, constipation, dry mouth, tachycardia, cognitive changes (2.32)"
]
},
" ",
{
"type":"p",
"hlId":"403ca6",
"class":"cell txt l",
"children":[
"Contraindications: glaucoma, hyperthyroidism"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"AMPA = α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; GABA = γ-aminobutyric acid; MTC= medullary thyroid carcinoma; MEN2 = multiple endocrine neoplasia type 2."
],
[
"Data from Khera R, Murad MH, Chandar AK, et al. Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis. JAMA. 2016;315:2424-34. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/27299618",
"target":"_blank"
},
"children":[
"PMID: 27299618"
]
},
" doi:10.1001/jama.2016.7602"
]
]
}